UBS Group AG - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOCXXXX and the CUSIP is 09072V402. A total of 17 filers reported holding BIOCEPT INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BIOCEPT INC
ValueSharesWeighting
Q2 2020$1,000
-95.0%
1,306
-98.3%
0.00%
Q1 2020$20,000
+122.2%
76,136
+148.0%
0.00%
Q4 2019$9,0000.0%30,695
+283.4%
0.00%
Q2 2019$9,000
+80.0%
8,006
+83.2%
0.00%
Q1 2019$5,0004,3700.00%
Other shareholders
BIOCEPT INC shareholders Q3 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,505$49,0000.01%
ROYAL BANK OF CANADA 35,053$30,0000.00%
VANGUARD GROUP INC 13,911$12,0000.00%
Advisory Services Network, LLC 12$00.00%
JANE STREET GROUP, LLC 13,165$11,0000.00%
DIMENSIONAL FUND ADVISORS LP 110,500$95,0000.00%
US BANCORP \DE\ 826$1,0000.00%
BANK OF AMERICA CORP /DE/ 32$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 82$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOCEPT INC shareholders